Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers-Reference-Cited by-同舟云学术

Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic 131I in the differentiated thyroid cancers

Published:2016-05-04 Issue:1 Volume:42 Page:42-48
ISSN:0743-5800
Container-title:Endocrine Research
language:en
Short-container-title:Endocrine Research

Author:

Trevizam Paula Grasiele Carvalho¹,Tagliarini José Vicente²,Castilho Emanuel Celice²,de Alencar Marques Mariângela³,Kiy Yoshio⁴,Mazeto Gláucia Maria Ferreira da Silva¹

Affiliation:

1. Internal Medicine Department, Botucatu Medical School, São Paulo State University, Unesp, Botucatu, SP, Brazil

2. Ophthalmology, Otorhinolaryngology and Head and Neck Surgery Department, Botucatu Medical School, São Paulo State University, Unesp, Botucatu, SP, Brazil

3. Pathology Department, Botucatu Medical School, São Paulo State University, Unesp, Botucatu, SP, Brazil

4. Tropical Diseases and Imaging Diagnosis Department, Botucatu Medical School, São Paulo State University, Unesp, Botucatu, SP, Brazil

Publisher

Informa UK Limited

Subject

Endocrinology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.3109/07435800.2016.1173056

Reference28 articles.

1. Thyroid Cancer Incidence Patterns in Sao Paulo, Brazil, and the U.S. SEER Program, 1997–2008

2. Predictive Value of Preablation Stimulated Thyroglobulin and Thyroglobulin/Thyroid-Stimulating Hormone Ratio in Differentiated Thyroid Cancer

3. Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus

4. Predictive Value of Serum Thyroglobulin After Surgery for Thyroid Carcinoma

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulating thyroglobulin to TSH ratio predict long-term efficacy of 131I therapy in patients with differentiated thyroid cancer after total thyroidectomy: a retrospective study;Endocrine;2024-01-03

2. A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate‑ and high‑risk differentiated thyroid cancer patients: a bi-center retrospective study;Endocrine;2023-12-12

3. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study;Frontiers in Endocrinology;2023-09-22

4. A Novel Nomogram Integrated with Preablation Stimulated Thyroglobulin and Thyroglobulin/Thyroid-Stimulating Hormone Ratio to Predict the Therapeutic Response of Intermediate‑ and High‑Risk Differentiated Thyroid Cancer Patients: a Bi-center Retrospective Study;2023-09-08

5. Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study;The Journal of Clinical Endocrinology & Metabolism;2023-06-02